+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 4ap4 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Rnf4 - ubch5a - ubiquitin heterotrimeric complex | ||||||
![]() |
| ||||||
![]() | LIGASE/SIGNALLING PROTEIN / LIGASE-SIGNALLING PROTEIN COMPLEX / CHIMERA | ||||||
機能・相同性 | ![]() response to human chorionic gonadotropin / regulation of spindle assembly / regulation of kinetochore assembly / SUMO polymer binding / Antigen processing: Ubiquitination & Proteasome degradation / positive regulation of protein polyubiquitination / Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase / Inactivation of APC/C via direct inhibition of the APC/C complex / APC/C:Cdc20 mediated degradation of mitotic proteins / Aberrant regulation of mitotic exit in cancer due to RB1 defects ...response to human chorionic gonadotropin / regulation of spindle assembly / regulation of kinetochore assembly / SUMO polymer binding / Antigen processing: Ubiquitination & Proteasome degradation / positive regulation of protein polyubiquitination / Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase / Inactivation of APC/C via direct inhibition of the APC/C complex / APC/C:Cdc20 mediated degradation of mitotic proteins / Aberrant regulation of mitotic exit in cancer due to RB1 defects / cellular response to testosterone stimulus / cellular response to hydroxyurea / Phosphorylation of the APC/C / cellular response to arsenic-containing substance / Signaling by BMP / protein K6-linked ubiquitination / (E3-independent) E2 ubiquitin-conjugating enzyme / response to arsenic-containing substance / protein K11-linked ubiquitination / ubiquitin conjugating enzyme binding / negative regulation of protein localization to chromatin / nuclear androgen receptor binding / E2 ubiquitin-conjugating enzyme / cellular response to cytokine stimulus / ubiquitin conjugating enzyme activity / Regulation of APC/C activators between G1/S and early anaphase / Transcriptional Regulation by VENTX / protein K63-linked ubiquitination / negative regulation of BMP signaling pathway / Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Membrane binding and targetting of GAG proteins / Endosomal Sorting Complex Required For Transport (ESCRT) / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Negative regulation of FLT3 / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / Constitutive Signaling by NOTCH1 HD Domain Mutants / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / NOTCH2 Activation and Transmission of Signal to the Nucleus / TICAM1,TRAF6-dependent induction of TAK1 complex / TICAM1-dependent activation of IRF3/IRF7 / APC/C:Cdc20 mediated degradation of Cyclin B / Regulation of FZD by ubiquitination / Downregulation of ERBB4 signaling / p75NTR recruits signalling complexes / protein K48-linked ubiquitination / APC-Cdc20 mediated degradation of Nek2A / InlA-mediated entry of Listeria monocytogenes into host cells / Regulation of pyruvate metabolism / TRAF6-mediated induction of TAK1 complex within TLR4 complex / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / Regulation of innate immune responses to cytosolic DNA / NF-kB is activated and signals survival / Downregulation of ERBB2:ERBB3 signaling / NRIF signals cell death from the nucleus / Pexophagy / nucleosome binding / VLDLR internalisation and degradation / protein autoubiquitination / Regulation of PTEN localization / Activated NOTCH1 Transmits Signal to the Nucleus / Regulation of BACH1 activity / MAP3K8 (TPL2)-dependent MAPK1/3 activation / Translesion synthesis by REV1 / Synthesis of active ubiquitin: roles of E1 and E2 enzymes / InlB-mediated entry of Listeria monocytogenes into host cell / Translesion synthesis by POLK / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / Downregulation of TGF-beta receptor signaling / Josephin domain DUBs / TICAM1, RIP1-mediated IKK complex recruitment / negative regulation of TORC1 signaling / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / positive regulation of protein ubiquitination / Translesion synthesis by POLI / Gap-filling DNA repair synthesis and ligation in GG-NER / IKK complex recruitment mediated by RIP1 / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / Regulation of activated PAK-2p34 by proteasome mediated degradation / TNFR1-induced NF-kappa-B signaling pathway / PINK1-PRKN Mediated Mitophagy / TCF dependent signaling in response to WNT / Autodegradation of Cdh1 by Cdh1:APC/C / N-glycan trimming in the ER and Calnexin/Calreticulin cycle / APC/C:Cdc20 mediated degradation of Securin / activated TAK1 mediates p38 MAPK activation / Regulation of NF-kappa B signaling / Asymmetric localization of PCP proteins / Ubiquitin-dependent degradation of Cyclin D / Regulation of signaling by CBL 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Plechanovova, A. / Hay, R.T. / Tatham, M.H. / Jaffray, E. / Naismith, J.H. | ||||||
![]() | ![]() タイトル: Structure of a Ring E3 Ligase and Ubiquitin-Loaded E2 Primed for Catalysis 著者: Plechanovova, A. / Jaffray, E. / Tatham, M.H. / Naismith, J.H. / Hay, R.T. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 248.9 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 200.8 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 454.2 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 456.8 KB | 表示 | |
XML形式データ | ![]() | 23 KB | 表示 | |
CIF形式データ | ![]() | 32.4 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 14758.155 Da / 分子数: 1 / 断片: RESIDUES 131-195,131-195 / 由来タイプ: 組換発現 詳細: THE RING DOMAIN IS DUPLICATED BUT AS A FUSED DIMER. THAT IS THE SEQUENCE OF THE RING DOMAIN FROM RNF4 (RESIDUES 131 TO 194) IS LINKED BY A SINGLE GLYCINE RESIDUE TO ANOTHER RING DOMAIN (RESIDUES 131 TO 194). 由来: (組換発現) ![]() ![]() ![]() ![]() 参照: UniProt: O88846, 合成酵素; C-N結合を形成; 酸-D-アミノ酸リガーゼ(ペプチド合成) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
#2: タンパク質 | 分子量: 17134.553 Da / 分子数: 2 / Mutation: YES / 由来タイプ: 組換発現 詳細: ISOPEPTIDE AMIDE LINKAGE OF C85K ON UBCH5A TO G76 OF UBIQUITIN CHAIN B LINKED TO CHAIN C (UBIQUITIN) CHAIN E LINKED TO CHAIN F (UBIQUITIN) 由来: (組換発現) ![]() ![]() ![]() #3: タンパク質 | 分子量: 8893.206 Da / 分子数: 2 / 断片: RESIDUES 76-152 / 由来タイプ: 組換発現 詳細: ISOPEPTIDE AMIDE LINKED TO UBCH5A (CHAIN B AND CHAIN E) 由来: (組換発現) ![]() ![]() ![]() #4: 化合物 | ChemComp-ZN / #5: 水 | ChemComp-HOH / | 構成要素の詳細 | ENGINEERED RESIDUE IN CHAIN B, SER 22 TO ARG ENGINEERED RESIDUE IN CHAIN B, CYS 85 TO LYS ...ENGINEERED | 配列の詳細 | THE PROTEIN IS A FUSION DIMER OF TWO MOLECULES OF RNF4. EACH DOMAIN IS SER 131 TO ILE 194. THE N- ...THE PROTEIN IS A FUSION DIMER OF TWO MOLECULES OF RNF4. EACH DOMAIN IS SER 131 TO ILE 194. THE N-TERMINUS HAS A GAMG EXTENSION. GLY 195 LINKS THE TWO SEQUENCES. THUS SER 196 CORRESPOND | |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.4 Å3/Da / 溶媒含有率: 49 % |
---|---|
結晶化 | pH: 7.2 / 詳細: pH 7.2 |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() |
検出器 | タイプ: RIGAKU SATURN 944 / 検出器: CCD / 日付: 2012年1月31日 / 詳細: MIRROR |
放射 | モノクロメーター: MIRRORS / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | 解像度: 2.21→190 Å / Num. obs: 32159 / % possible obs: 99.2 % / Observed criterion σ(I): 0 / 冗長度: 10.6 % / Rmerge(I) obs: 0.03 / Net I/σ(I): 43.9 |
反射 シェル | 解像度: 2.21→2.26 Å / 冗長度: 3.5 % / Rmerge(I) obs: 0.17 / % possible all: 92 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB ENTRIES 2YH0 1UBQ 2XEU 解像度: 2.21→94.82 Å / Cor.coef. Fo:Fc: 0.934 / Cor.coef. Fo:Fc free: 0.923 / SU B: 11.981 / SU ML: 0.162 / 交差検証法: THROUGHOUT / ESU R: 0.301 / ESU R Free: 0.215 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES WITH TLS ADDED
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: BABINET MODEL WITH MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 42.181 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.21→94.82 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
|